Ultragenyx Pharmaceutical reported $1.38B in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Aptinyx Inc APTX:US $ 106.65M 8.27M
Biocryst Pharmaceuticals BCRX:US $ 527.72M 60.43M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Epizyme EPZM:US $ 312.19M 23.19M
Esperion Therapeutics ESPR:US $ 342.85M 38.74M
Insmed INSM:US $ 1.15B 90.19M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Kyowa Hakko Kirin 4151:JP Y 907816M 14056M
Macrogenics MGNX:US $ 271.44M 63.8M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Moderna Inc MRNA:US 27.61B 2.94B
Ptc Therapeutics PTCT:US $ 1799.59M 138.46M
Puma Biotechnology PBYI:US $ 200.68M 25.9M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
Vital Therapies VTL:US $ 149.92M 10.82M
Xoma XOMA:US $ 159.16M 7.4M